TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 54 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $315,000 | +2150.0% | 67,976 | +3606.4% | 0.00% | – |
| Q3 2015 | $14,000 | -99.3% | 1,834 | -95.7% | 0.00% | -100.0% |
| Q2 2015 | $2,037,000 | -12.9% | 42,937 | -32.7% | 0.00% | -25.0% |
| Q1 2015 | $2,339,000 | -32.6% | 63,831 | -26.5% | 0.00% | -33.3% |
| Q4 2014 | $3,472,000 | +58.4% | 86,811 | -21.0% | 0.01% | +50.0% |
| Q3 2014 | $2,192,000 | +219100.0% | 109,896 | +174338.1% | 0.00% | – |
| Q3 2013 | $1,000 | – | 63 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |